Role of steroid hormones and prolactin in canine mammary cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 94, Issue 1-3 SPEC. ISS., 2005, Pages 181-187

  Queiroga, F L ^a   Perez Alenza M D ^b   Silvan, G ^b   Pena L ^b   Lopes, C ^c   Illera, J C ^b  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Androstenedione; Canine; Dyhidroepiandrostenedione; Estradiol; Estrone sulphate; Mammary; Progesterone; Prolactin; Serum; Steroid hormones; Testosterone; Tumours

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTRONE SULFATE; PRASTERONE; PROGESTERONE; PROLACTIN; STEROID HORMONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; DOG; DYSPLASIA; ELECTROIMMUNOASSAY; ENZYME IMMUNOASSAY; FEMALE; HORMONE ACTION; HORMONE BLOOD LEVEL; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; TISSUE HOMOGENATE;

ANIMALIA; CANIS FAMILIARIS;

EID: 18244375836     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.12.014     Document Type: Article

References (51)

1. C.R. Dorn, D.O.N. Taylor, R. Schneider, H.H. Hibbard, and M.R. Klauiber Survey of animal neoplasms in Alameda and Contra Costa Counties, California J. Natl. Cancer Inst. 40 1968 307 318
2. R. Schneider, C.R. Dorn, and D.O.N. Taylor Factores influencing canine mammary cancer development and postsurgical survival J. Natl. Cancer Inst. 43 1969 1249 1261
3. W. Misdorp, and A.A.M. Hart Prognostic factors in canine mammary cancer J. Natl. Cancer Inst. 56 1976 779 786
4. E. Helmén, R. Bergström, L. Holmberg, I.B. Splingberg, K. Hansson, and A. Lindgren Prognostic factors in canine mammary tumours: a multivariate study of 202 consecutive cases Vet. Pathol. 30 1993 20 27
5. J.A. Mol, P.J. Selman, E.P. Sprang, J.W. van Neck, and M.A. Oosterlaken-Dijksterhuis The role of progestins, insulin-like growth factor (IGF) and binding proteins in the normal and neoplastic mammary gland of the bitch: a review J. Reprod. Fertil. Suppl. 51 1997 339 344
6. M. Geraldes, F. Gardner, and F. Schmitt Immunohistochemical study of hormonal receptors and cell proliferation in normal and canine mammary glands and spontaneous mammary tumours Vet. Rec. 146 2000 403 406
7. A. Nieto, L. Peña, M.D. Pérez-Allenza, M.A. Sánchez, J.M. Flores, and M. Castaño Immunohistologic detection of estrogen receptor alpha in canine mammary tumours: clinical and pathologic associations and prognostic significance Vet. Pathol. 37 2000 239 247
8. M.D. Perez-Alenza, L. Peña, N. del Castillo, and A.I. Nieto Factores influencing the incidence and the prognosis of canine mammary tumours J. Small Anim. Practice 41 7 2000 287 291
9. L. Peña, G. Silvan, M.D. Pérez-Alenza, A. Nieto, and J.C. Illera Steroide hormone profile of canine mammary carcinoma: a preliminary study J. Steroid Biochem. Mol. Biol. 84 2003 211 216
10. A.L. Parodi, J.P. Mialot, and P.M. Martin Canine and feline mammary cancers as animal models for hormone-dependent human breast tumors: relationships between steroid receptor profiles and survival rates Prognosis Cancer Res. Ther. 31 1984 357 365
11. W. Misdorp Canine mammary tumours: protective effect of late ovariectomy and stimulating effects of progestins Vet. Quart. 10 1988 26 33
12. G.R. Rutteman Hormones and mammary tumour disease in the female dog: an update In vivo 4 1990 33 40
13. G.R. Rutteman, and W. Misdop Hormonal background of canine and feline mammary tumours J. Reprod. Fert. Suppl. 47 1993 483 487
14. G.R. Rutteman, N. Willekes-Koolschijn, M.M. Bevers, A.a. Van Der Gugten, and W. Misdorp Prolactin binding in benign and malignant mammary tissue of female dogs Anticancer Res. 6 1986 829 835
15. G.R. Rutteman, M.M. Bevers, W. Misdorp, and W.E. Van den Brom Anterior pituitary function in female dogs with mammary tumours. II. Prolactin Anticancer Res. 9 1989 241 246
16. M.E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: structure, function, and regulation of secretion Physiol. Rev. 2000 1523 1631
17. O. Riddle, R.W. Bates, and S.W. Dykshorn The preparation, identification and assay of prolactin - a hormone of the anterior pituitary Am. J. Physiol. 1 1938 191 216
18. N. Ben-Jonathan, J.L. Mershon, D.L. Allen, and R.W. Steinmetz Extrapituitary prolactin: distribution, regulation, functions, clinical aspects Endocrinol. Rev. 17 1996 639 669
19. M. Llovera, P. Touraine, P. Kelly, and V. Goffin Involvement of prolactin in breast cancer: redefining the molecular targets Exp. Gerontol. 2000 41 51
20. H. Wenbo, M. Gebre-Medhin, A. Gritli-Linde, C. Ohlsson, O.G. Isaksson, and J. Tornell Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumours in transgenic mice J. Clin. Investigat. 1 1997 2744 2751
21. S.E. Hankinson, W.C. Willett, D.S. Michaud, J.E. Manson, G.A. Colditz, C. Longcope, B. Rosner, and F.E. Speizer Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women J. Natl. Cancer Inst. 1999 629 634
22. P.G. Saluja, J.M. Hamilton, M. Gronow, and W. Misdorp Pituitary prolactin levels in canine mammary cancer Eur. J. Cancer 1974 63 66
23. J.M. Hamilton, P.J. Knight, and J. Beevers Serum prolactin concentrations in canine mammary cancer Vet. Rec. 1978 127 128
24. M.F. El Etreby, R. Muller-Peddinghaus, A.S. Bhargava, M.R. Fath El Babm, K.J. Graf, and G. Trautwein The role of pituitary gland in spontaneous canine mammary tumorigenesis Vet. Pathol. 1980 2 16
25. C.J. Ormandy, R.E. Hall, D.L. Manning, J.F.R. Robertson, R.W. Blamey, P.a. Kelly, R.I. Nicholson, and R.L. Sutherland Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer J. Clin. Endocrinol. Metabol. 1997 3692 3699
26. J.H. Gutzman, K.K. Miller, and L.A. Schuler Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alfa and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells J. Steroid Biochem. Mol. Biol. 1 2004 69 77
27. L.N. Owen TNM Classification of Tumours in Domestic Animals first ed. 1980 WHO Geneva
28. W. Misdorp, R.W. Else, E. Helmén, and T.P. Lipscomb Histological Classification of Mammary tumours of the Dog and Cat, Second Series vol. 7 1999 Armed Forces institute of Pathology and World Health Organization Washington
29. J.M. Bhatavdekar, D.D. Patel, N.G. Shah, H.H. Vora, T.P. Suthar, N. Ghosh, P.R. Chikhlikar, T.I. Trivedi, G.V. Sherbert, D.D. Giri, N.H. Karelia, H.H. Vora, N.G. Shah, T.P. Suthar, S.P. Nadkarni, and D.B. Balar Prognostic significance of plasma prolactin in breast cancer: Comparison with the expression of c-erb B-2 oncoprotein Eur. J. Surg. Oncol. 1993 409 414
30. S.E. Hankinson, W.C. Willett, D.S. Michaud, J.E. Manson, G.A. Colditz, C. Longcope, B. Rosner, and F.E. Speizer Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women J. Natl. Cancer Inst. 7 1999 629 634
31. D.D. Patel, J.M. Bhatavdekar, P. Chikhlikar, N. Ghosh, T.P. Suthar, N.G. Shah, R.H. Mehta, and D.B. Balar Node-negative breast carcinoma: hiperprolactinemia/overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators J. Surg. Oncol. 1996 86 92
32. M. Nicol, C. Willis, C. Yiangou, D. Sinnett, and S. Shousha Relationship between serum prolactin levels and histology of benign and malignant breast lesions: a detailed study of 153 consecutive cases Breast J. 8 5 2002 281 285
33. C.V. Clevenger, and T.L. Plank Prolactin as an autocrine/paracrine factor in breast tissue J. Mammary Gland Biol. Neoplasia 2 1997 59 68
34. E. Ginsburg, and B.K. Vonderhaar Prolactin synthesis and secretion by human breast cancer cells Cancer Res. 1995 2591 2595
35. C.M. Shaw-Bruha, S.J. Pirrucello, and J.D. Shull Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing Breast Cancer Res. Treat. 44 1997 243 253
36. N. Ben-Jonathan, K. Liby, M. McFarland, and M. Zinger Prolactin as an autocrine/paracrine growth factor in human cancer Trends Endocrinol. Metabolism 6 2002 245 250
37. C.V. Clevenger, P.A. Furth, S.E. Hankinson, and L.A. Shuler The role of prolactin in mammary carcinoma Endocrine Rev. 1 2003 1 27
38. B.K. Vonderhaar Prolactin involvement in breast cancer Endocrine-Relat. Cancer 6 1999 389 404
39. V. Goffin, N. Binart, P. Touraine, and P.A. Kelly Prolactin: the new biology of an old hormone Annu. Rev. Physiol. 2002 47 67
40. J.M. Bhatavdekar, D.D. Patel, N.G. Shah, H.H. Vora, T.P. Suthar, N. Ghosh, P.R. Chikhlikar, and T.I. Trivedi Prolactin as a local growth promoter in patients with breast cancer: GCRI experience Eur. J. Surg. Oncol. 2000 540 547
41. H. Wennbo, and J. Törnell The role of prolactin and growth hormone in breast cancer Oncogene 2000 1072 1076
42. J.H. Thijssen, A.A. van Landeghem, and J. Poortman Uptake and concentration of steroid hormones in mammary tissues Ann. N.Y. Acad. Sci. 4 1986 106 116
43. J.H. Thijssen, and M.A. Blankenstein Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues Eur. J. Clin. Oncol. 1989 1953 1959
44. P. Ebeling, and V.A. Koivisto Physiological importance of dehydroepiandrosterone Lancet 3 8911 1994 1479 1481
45. C.S. Chetrite, J. Cortes-Prieto, J.C. philippe, F. Wright, and J.R. Pasqualini Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues J. Steroid Biochem. Mol. Biol. 1-2 2000 23 27
46. J. Geisler Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators J. Steroid Biochem. Mol. Biol. 3-5 2003 245 253
47. T. Suzuki, T. Moriya, T. Ishida, N. Ohuchi, and H. Sasano Intracrine Mechanism of estrogen synthesis in breast cancer Biomed. Pharmacotherapy 2003 460 462
48. M.P. Leondires, Z.Z. Hu, J. Dong, C.H. Tsai-Morris, and M.L. Dufau Estradiol stimulates expression of two human prolactin receptor isoforms with alternative exons-1 in T47D breast cancer cells J. Steroid Biochem. Mol. Biol. 2-3 2002 263 268
49. L. DaSilva, H. Rui, R.A. Erwin, O.M. Howard, R.A. Kirken, M.G. Malabarba, R.H. Hackett, A.C. Larner, and W.L. Farrar Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR5and TYR580 Mol. Cell Endocrinol. 1 1996 131 140
50. B.K. Vonderhaar Prolactin: the forgotten hormone of human breast cancer Pharmacol. Ther. 2 1998 169 178
51. E.L. Gregoraszczuk, T. Milewicz, J. Kolodziejczyk, J. Krzysiek, A. Basta, K. Sztefko, S. Kurek, and J. Stachura Progesterone-induced secretion of growth hormone, insulin-like growth factor and prolactin by human breast cancer explants Gynecol. Endocrinol. 4 2001 251 258